UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of distinctive interferon gene signatures in different types of myositis

Neurology, 2019-09, Vol.93 (12), p.e1193

2019

Volltextzugriff (PDF)

Autoimmunity: The History of an Idea

Arthritis & rheumatology (Hoboken, N.J.), 2014-11, Vol.66 (11), p.2915-2920

Plotz, Paul H.

2014

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis

Seminars in arthritis and rheumatism, 2018-06, Vol.47 (6), p.858-864

2018

Volltextzugriff (PDF)

Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease

Annals of neurology, 2006-04, Vol.59 (4), p.700-708

2006

Volltextzugriff (PDF)

The autoantibody repertoire: searching for order

Nature reviews. Immunology, 2003-01, Vol.3 (1), p.73-78

Plotz, Paul H

2003

Volltextzugriff (PDF)

Fiber type conversion by PGC-1α activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle

PloS one, 2010-12, Vol.5 (12), p.e15239-e15239

2010

Volltextzugriff (PDF)

Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder-murine Pompe disease

Autophagy, 2010-11, Vol.6 (8), p.1078-1089

2010

Volltextzugriff (PDF)

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

Arthritis care & research (2010), 2010-04, Vol.62 (4), p.465-472

2010

Volltextzugriff (PDF)

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

The Journal of experimental medicine, 2005-02, Vol.201 (4), p.591-601

2005

Volltextzugriff (PDF)

Autophagy and Mistargeting of Therapeutic Enzyme in Skeletal Muscle in Pompe Disease

Molecular therapy, 2006-12, Vol.14 (6), p.831-839

2006

Volltextzugriff (PDF)

A tribute to Norman Talal

The Journal of clinical investigation, 2015-08, Vol.125 (8), p.2910-2911

2015

Volltextzugriff (PDF)

Autophagy and Lysosomes in Pompe Disease

Autophagy, 2006-10, Vol.2 (4), p.318-320

2006

Volltextzugriff (PDF)

When more is less: Excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease

Autophagy, 2009-01, Vol.5 (1), p.111-113

2009

Volltextzugriff (PDF)

Deconstructing Pompe Disease by Analyzing Single Muscle Fibers: "To See a World in a Grain of Sand..."

Autophagy, 2007-11, Vol.3 (6), p.546-552

2007

Volltextzugriff (PDF)

Chapter 21 Monitoring Autophagy in Lysosomal Storage Disorders

Methods in Enzymology, 2009, Vol.453, p.417-449

2009

Volltextzugriff (PDF)

Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy

Molecular genetics and metabolism, 2010-12, Vol.101 (4), p.324-331

2010

Volltextzugriff (PDF)

Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells

The Journal of experimental medicine, 2002-09, Vol.196 (6), p.781-791

2002

Volltextzugriff (PDF)

Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches

Molecular genetics and metabolism, 2009-04, Vol.96 (4), p.208-217

2009

Volltextzugriff (PDF)

Replacing acid α-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers

Molecular therapy, 2005-01, Vol.11 (1), p.48-56

2005

Volltextzugriff (PDF)

Conditional up-Regulation of MHC Class I in Skeletal Muscle Leads to Self-Sustaining Autoimmune Myositis and Myositis-Specific Autoantibodies

Proceedings of the National Academy of Sciences - PNAS, 2000-08, Vol.97 (16), p.9209-9214

2000

Volltextzugriff (PDF)

70 years of progress: history of the Rheumatism Society of the District of Columbia, 1946–2016

International journal of rheumatic diseases, 2017-12, Vol.20 (12), p.2258-2261

2017

Volltextzugriff (PDF)

Correction of the Enzymatic and Functional Deficits in a Model of Pompe Disease Using Adeno-associated Virus Vectors

Molecular therapy, 2002-05, Vol.5 (5), p.571-578

2002

Volltextzugriff (PDF)

Acid alpha-glucosidase deficiency (Pompe disease)

Current neurology and neuroscience reports, 2007-01, Vol.7 (1), p.71-77

2007

Volltextzugriff (PDF)

The values and limits of an in vitro model of Pompe disease: The best laid schemes o' mice an' men ........

Autophagy, 2009-07, Vol.5 (5), p.729-731

2009

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(186)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(239)
Japanisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Humans
(136)
Life Sciences & Biomedicine
(134)
Female
(66)
Animals
(62)
Male
(50)
Adult
(47)
Biological And Medical Sciences
(47)
Mice
(39)
Medical Sciences
(36)
Rheumatology
(36)
Middle Aged
(26)
General & Internal Medicine
(24)
Immunology
(24)
Medicine, General & Internal
(24)
Myositis - Immunology
(24)
Genetics & Heredity
(19)
Glycogen Storage Disease Type Ii - Genetics
(19)
Proteins
(18)
Biochemistry & Molecular Biology
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Identification of distinctive interferon gene signatures in different types of myositis

Autoimmunity: The History of an Idea

A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis

Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease

The autoantibody repertoire: searching for order

Fiber type conversion by PGC-1α activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle

Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder-murine Pompe disease

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

Autophagy and Mistargeting of Therapeutic Enzyme in Skeletal Muscle in Pompe Disease

A tribute to Norman Talal

Autophagy and Lysosomes in Pompe Disease

When more is less: Excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease

Deconstructing Pompe Disease by Analyzing Single Muscle Fibers: "To See a World in a Grain of Sand..."

Chapter 21 Monitoring Autophagy in Lysosomal Storage Disorders

Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy

Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells

Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches

Replacing acid α-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers

Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies

Conditional up-Regulation of MHC Class I in Skeletal Muscle Leads to Self-Sustaining Autoimmune Myositis and Myositis-Specific Autoantibodies

70 years of progress: history of the Rheumatism Society of the District of Columbia, 1946–2016

Correction of the Enzymatic and Functional Deficits in a Model of Pompe Disease Using Adeno-associated Virus Vectors

Acid alpha-glucosidase deficiency (Pompe disease)

The values and limits of an in vitro model of Pompe disease: The best laid schemes o' mice an' men ........

Suchergebnisse filtern